This site is intended for health professionals only

Interferon-b: first-line therapy in multiple sclerosis

teaser

Per Soelberg Sorensen

Article continues below this sponsored advert
Advertisement

Danish Multiple Sclerosis Centre,

University of Copenhagen and Department of Neurology, Rigshospitalet, Copenhagen, Denmark

Approximately 85% of patients with multiple sclerosis (MS) have a relapsing






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x